Stock analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for shares of Theratechnologies in a note issued to investors on Friday, October 11th. Cantor Fitzgerald ...
Globally, the prevalence of multidrug-resistant tuberculosis (MDR-TB) has been increasing recently. This is a major public health concern, as MDR-TB is more difficult to treat and has poorer outcomes ...
Omitting the 5-fluorouracil bolus from multidrug regimens could improve the tolerability of treatment without compromising efficacy in patients with advanced gastrointestinal cancers, a new study ...
This week, a phase 3 clinical trial showed aztreonam-avibactam might be treatment option for patients facing multidrug-resistant infections. Meanwhile, research shows that penicillin allergies in ...
IDWeek is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases ...